Related Experiment Video
Updated: Aug 9, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
[New strategies in multiple organ dysfunction syndrome therapy for sepsis]
Abstract:
Despite more than 20 years of extensive research, sepsis and/or trauma induced multiple organ dysfunction syndrome (MODS) remain the chief cause of death in intensive care units, with mortality rates between 30% and 80%. Early goal-directed therapy (EGDT), use of drotrecogin alfa (activated), tight control of hyperglycaemia, and adrenal replacement therapy (low doses of corticosteroids), all constitute new treatment strategies. In future, a combination of therapies should be individually adjusted for each patient.
Insights
Multiple organ dysfunction syndrome (MODS) from sepsis or trauma is a leading intensive care unit cause of death. Future treatments will combine therapies tailored to individual patients.
Area of Science:
- Critical care medicine
- Pathophysiology of organ dysfunction
- Trauma and sepsis research
Context:
- Multiple organ dysfunction syndrome (MODS) remains a significant challenge in intensive care units (ICUs).
- Sepsis and trauma are primary triggers for MODS, contributing to high mortality rates (30-80%).
- Despite extensive research over two decades, effective treatments are still evolving.
Purpose:
- To review current and emerging treatment strategies for sepsis/trauma-induced MODS.
- To highlight the need for personalized therapeutic approaches in critical care.
Summary:
- New treatment strategies include early goal-directed therapy (EGDT), drotrecogin alfa (activated), strict glycemic control, and low-dose corticosteroid therapy.
- These interventions aim to mitigate organ damage and improve survival in critically ill patients.
- The abstract emphasizes that a combination of therapies, individually adjusted, is crucial for future management.
Impact:
- Improved understanding of MODS pathophysiology and treatment options.
- Potential for enhanced patient outcomes and reduced mortality in ICUs.
- Guidance for clinicians on integrating novel therapies into patient care protocols.
More Related Videos
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Heart Failure V: Medical Management
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
